Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 4, 2007 - Issue 2
Submit an article Journal homepage
196
Views
19
CrossRef citations to date
0
Altmetric
Editorial

Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patients

EM Westerman Clinical pharmacist, Haga Teaching Hospital/Apotheek Haagse Ziekenhuizen, The Hague, The Netherlands, P.O. Box 43100, 2504 AC The Hague, The Netherlands. [email protected]
,
HGM Heijerman Lung physician, Haga Teaching Hospital, Adult cystic fibrosis centre, P.O. Box 40551, 2504 LN, The Hague, The Netherlands
&
HW Frijlink Professor, University of Groningen, Department of Pharmaceutical Technology and Biopharmacy, Ant. Deusinglaan 1, 9713 AV Groningen, The Netherlands
Pages 91-94 | Published online: 05 Mar 2007

Bibliography

  • Cystic Fibrosis Foundation National Patient Registry Annual Data Report 2000 and 2004. Bethesda (MD): Cystic Fibrosis Foundation (2001,2005)
  • KULICH M, ROSENFELD M, GOSS CH, WILMOTT R. Improved survival among young patients with cystic fibrosis. J. Pediatr. (2003) 142:631-636.
  • RAMSEY BW, PEPE MS, QUAN JM et al: Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N. Engl. J. Med. (1999) 340:23-30.
  • TIDDENS HA: Detecting early structural lung damage in cystic fibrosis. Pediatr. Pulmonol. (2002) 34:228-231.
  • LE BRUN PP, DE BOER AH, GJALTEMA D, HAGEDOORN P, HEIJERMAN HG, FRIJLINK HW. Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer. Int. J. Pharm. (1999) 189:205-214.
  • BOE J, DENNIS JH, O’DRISCOLL BR et al.: European Respiratory Society Guidelines on the use of nebulizers. Eur. Respir. J. (2001) 18:228-242.
  • LE BRUN PP, VINKS, AA, TOUW DJ et al.: Can tobramycin inhalation be improved with a jet nebulizer? Ther. Drug. Monit. (1999) 21:618-24
  • BYRNE NM, KEAVEY PM, PERRY JD, GOULD FK, SPENCER DA: Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis. Arch. Dis. Child. (2003) 88:715-718.
  • KASTELIK JA, WRIGHT GA, AZIZ I et al.: A widely available method for the assessment of aerosol delivery in cystic fibrosis. Pulm. Pharmacol. Ther. (2002) 15:513-519
  • MARSDEN RJ, CONWAY SP, DODD ME et al.: Comparison of the HaloLite adaptive aerosol delivery (AAD®) system with a high output nebuliser system in cystic fibrosis patients. Thorax (2002) 57:48-94 (P114).
  • NEWHOUSE MT, HIRST PH, DUDDU SP et al.: Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers. Chest (2003) 124:360-366.
  • GOLDMAN JM, BAYSTON SM, O’CONNOR S, MEIGH RE: Inhaled micronised gentamicin powder: a new delivery system. Thorax (1990) 45:939-940.
  • CROWTHER LABIRIS NR, HOLBROOK AM, CHRYSTYN H, MACLEOD SM, NEWHOUSE MT: Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis. Am. J. Respir. Crit. Care Med. (1999) 160:1711-1716.
  • LE BRUN PP, DE BOER AH, MANNES GP et al.: Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients. Eur. J. Pharm. Biopharm. (2002) 54:25-32.
  • WESTERMAN EM, DE BOER AH, LE BRUN PP et al.: Dry powder inhalation of colistin in cystic fibrosis patients: a single dose pilot study. J. Cyst. Fibros. (2006) doi:10.1016/j.jcf.2006.10.010 (In press).
  • DE BOER AH, HAGEDOORN P, WESTERMAN EM, LE BRUN PP, HEIJERMAN HG, FRIJLINK HW: Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer®) for high powder doses. Eur. J. Pharm. Sci. (2006) 28:171-178.
  • WESTERMAN EM, DE BOER AH, LE BRUN PP, TOUW DJ, FRIJLINK HW, HEIJERMAN HG: Dry powder inhalation of colistin sulphomethate in healthy volunteers: a pilot study. Int. J. Pharmaceut. (2006) doi:10.1016/j.ijpharm.2006.11.021 (In press).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.